丛斌斌, 曹晓珊, 于金明. Recent advances in sentinel lymph node biopsy for early stage breast cancer[J]. China Oncology, 2018, 28(3): 236-240. DOI: 10.19401/j.cnki.1007-3639.2018.03.011.
Recent advances in sentinel lymph node biopsy for early stage breast cancer
With the rapid development of medical imaging techniques
the diagnosis of axillary lymph node metastases is improved in early stage breast cancer. The smaller and earlier metastatic lesion can be detected and identified by fine needle aspiration cytology or core needle biopsy
which may provide the entire axillary staging for patient. There are two prospective
multicenter
international randomized trials to compare axillary sentinel lymph node biopsy with no surgical staging for patients with negative axillary ultrasound imaging. Our center used contrastenhanced ultrasonography with microbubbles to identify the location of sentinel lymph node and guide its biopsy
which aimed to find an ultra-minimally invasive sentinel lymph node biopsy technique. The pre-operation imaging detection increased the detection rate of clinically positive axillary lymph node. However
it led some patients to lose the chance that they could receive axillary sentinel lymph node biopsy instead of axillary lymph node dissection. We also discussed whether sentinel lymph node biopsy suited cT1-2N0 patients who had 1-2 abnormal axillary lymph nodes detected by imaging technique and confirmed by fine needle aspiration cytology or core needle biopsy. Furthermore
the studies about internal mammary sentinel lymph node biopsy were reviewed.
Guidelines for breast cancer diagnosis and treatment by China Anti-Cancer Association (2026 edition)
Progress and prospects of CENPA-driven chromosomal instability in breast cancer: mechanisms, prognostic implications, and therapeutic perspectives
A study of 30-year trends in incidence and mortality risks of breast cancer among young women in China
Impact of miR-193a-3p on migration and invasion of breast cancer stem cells through targeting TRIM14
Axillary management after neoadjuvant therapy for breast cancer and optimization of sentinel lymph node diagnosis and treatment
Related Author
The Society of Breast Cancer China Anti-Cancer Association
Breast Oncology Group of the Oncology Branch of the Chinese Medical Association
LU Ye
ZHANG Wenxiang
KONG Xiangyi
FANG Yi
WANG Jing
GAO Jidong
Related Institution
Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital& Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Department of Cancer Prevention, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University
Shanghai Engineering Research Center of Artificial Intelligence Technology for Tumor Diseases
Department of Laboratory Medicine, Xingtai People’s Hospital